I really think what you've had here is that they've all had the same issue, losing product patents. It's hard to simply offset that with cost cutting, but it's nothing systemic in the company.

240

Pharmacia reported earnings growth of 19 percent, but the pharmaceutical side was up more than 20 percent by itself, so that's the sustainable long-term piece when they spin off agriculture.

129

There were no surprises from AHP. I think that's a good trend in general.

121